How is the MaxCyte Inc today?

The MaxCyte Inc today is trading in the down by -3.19% at 2.73.

How has MaxCyte Inc performed historically?

The MaxCyte Inc is currently trading down -3.19% on an intraday basis in the past week the index fell -5.21%. The index has been down -39.33% in the past quarter and fell -27.59% in the past year. You can view this in the overview section.

What is MaxCyte Inc Annual Revenue?

MaxCyte Inc Annual Revenue fell 6.44%, in the last year to $38.63 M. Its sector's average revenue growth for the last fiscal year was 7.48%.

What is MaxCyte Inc Annual Net Profit?

MaxCyte Inc Annual Net Profit fell 8.26% in the last year to $41.06 M. Its sector's average net profit growth for the last fiscal year was -33.01%.

What is MaxCyte Inc Price to Earning Ratio?

MaxCyte Inc Price to Earning Ratio is -7.05, which is negative.

What is MaxCyte Inc Stock Price?

MaxCyte Inc Stock Price fell 27.59% and underperformed its sector by 36.41% in the past year.

What is MaxCyte Inc Quarterly Revenue?

MaxCyte Inc Quarterly Revenue fell 44.51% YoY to $8.69 M. Its sector's average revenue growth YoY for the quarter was 5.56%.

What is MaxCyte Inc Quarterly Net profit?

MaxCyte Inc Quarterly Net profit fell 100.78% YoY to $10.6 M. Its sector's average net profit growth YoY for the quarter was -31.14%.

What is MaxCyte Inc Debt to Equity Ratio?

MaxCyte Inc Debt to Equity Ratio of 0.09 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is MaxCyte Inc Return on Equity(ROE)?

MaxCyte Inc Return on Equity(ROE) for the last financial year was -18.73%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is MaxCyte Inc Mutual Fund Holding?

MaxCyte Inc Mutual Fund Holding increased by 0.02% in the last quarter to 46.19.

What is MaxCyte Inc Institutional Holding?

MaxCyte Inc Institutional Holding increased by 0.95% in the last quarter to 70.1.

MaxCyte Inc XNAS: MXCT

MaxCyte Inc Live Share Price Today, Share Analysis and Chart

Name: MaxCyte Inc: Is Infosys Ltd. worth buying?
Item: MaxCyte Inc
Rating: 1.1878055
Author: Trendlyne DVM scores

Weak Stock

about

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and developme...

2.73 -0.09 (-3.19%)

48.10% Fall from 52W High

59,510 XNAS Volume

XNAS 05 May, 2025 10:58 AM (EDT)

Board Meeting

The next board meeting for MaxCyte Inc is on 07 May 2025 for the purpose of MaxCyte Inc First Quarter Earnings Conference Call for 2025 See details

Low Financial Strength

22.2 / 100

Expensive Valuation

16.5 / 100

Technically Bearish

34.1 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 168%

3 analysts

MaxCyte Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

MaxCyte Inc Live Share Price Today, Share Analysis and Chart

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and developme...

48.10% Fall from 52W High

SWOT Analysis

MaxCyte Inc Live Price Chart

MaxCyte Inc FAQ

How is MaxCyte Inc today?

MaxCyte Inc today is trading in the red, and is down by -3.19% at 2.73.

How has MaxCyte Inc performed historically?

MaxCyte Inc is currently trading down -3.19% on an intraday basis. In the past week the stock fell -5.21%. stock has been down -39.33% in the past quarter and fell -27.59% in the past year. You can view this in the overview section.